News - Page 5 of 12 - Leukaemia Care

1st April 2022

Leukaemia Care partners with Dalata Hotels in England, Scotland and Wales for the next three years

Dalata Hotel Group announce three new charity partners Marie Keating Foundation, Leukaemia Care and Air Ambulance Northern Ireland all set to benefit over three-year partnership.

16th December 2021

New treatment option for AML patients approved in England, thanks to campaign by Leukaemia Care

The National Institute for Health and Care Excellence (NICE) have made recommendations for venetoclax in combination with azacitidine to become available as an NHS treatment option for acute myeloid leukaemia (AML) in England.

10th December 2021

Leukaemia Care and Lymphoma Action release new patient information booklet on CLL and SLL

Leukaemia Care are pleased to announce our new patient information booklet in collaboration with Lymphoma Action about chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL).

17th November 2021

Leukaemia Care and the MPN Voice successfully campaign for patients with myelofibrosis to access new treatment

The National Institute for Health and Care Excellence (NICE) have today made recommendations for fedratinib for myelofibrosis (MF) to become available as an NHS treatment option patients for a period of time in England.

24th September 2021

Leading leukaemia charities call on Rishi Sunak not to cut lifeline for blood cancer patients currently on furlough

Leading blood cancer charities have today (24th September) sent a letter to Chancellor Rishi Sunak, calling on him to continue financial support for leukaemia and other blood cancer patients currently on furlough as a result of the COVID-19 pandemic.

3rd September 2021

Latest on the COVID-19 spring booster

This article provides information on the latest COVID-19 booster programme.

2nd September 2021

Leukaemia Care and OPAAL team up for Blood Cancer Awareness Month

We've teamed up with the Older People's Advocacy Alliance (OPAAL) to raise awareness of leukaemia in the 65+ community. Find out more about our collaboration.

18th August 2021

Leukaemia Care and the UK Mastocytosis Support Group successfully campaign for patients with very rare condition to access new treatment

The National Institute for Health and Care Excellence (NICE) have made recommendations for midostaurin to become an NHS treatment option for advanced systemic mastocytosis (AdvSM) patients in England. This decision follows a 4  year  long campaign by Leukaemia Care, The UK Mastocytosis Support Group and affected patients. 

12th August 2021

Leukaemia Care takes steps to show support for the LGBTQ+ community

To show the charity's support for the LGBTQ+ community, Leukaemia Care have taken the decision to include staff members' pronouns in their email signatures. Find out more about this decision here.

14th July 2021

Many leukaemia patients face a devastating choice as ‘Freedom Day’ looms: their life or their livelihood?

“Many people living with leukaemia feel they have been forgotten about in the rush to ease COVID-19 restrictions." Here, you can find out what we are doing to help support clinically extremely vulnerable (CEV) leukaemia patients, ensuring they have a voice.